Uveitis in a Patient Receiving Rifabutin for Crohn's Disease

Shafran I. , Kugler L. , El-Zaatari F.A. , Naser S.A. , Sandoval J. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Dig Liver Dis 2002; 34: 22–8

Gui G.P. , Thomas P.R. , Tizard M.L. . Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother 1997; 39: 393–400

Shafran S.D. , Singer J. , Zarowny D.P. . Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group. J Infect Dis 1998; 177: 252–5

Arevalo J.F. , Russack V. , Freeman W.R. New ophthalmic manifestations of presumed rifabutin-related uveitis. Ophthalmic Surg Lasers 1997; 28: 321–4

Bhagat N. , Read R.W. , Rao N.A. , Smith R.E. , Chong L.P. Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals. Ophthalmology 2001; 108: 750–2

Saran B.R. , Maguire A.M. , Nichols C. . Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol 1994; 112: 1159–65